U.S. Gastroenterologists Endorse Fiber Choice® Chewable Prebiotic Fiber Supplement With A "#1-Recommended" Rating
BOCA RATON, Fla., Aug. 23, 2019 /PRNewswire/ -- IM HealthScience® (IMH), innovators of medical foods and dietary supplements, today announced that a high-quality, nationwide survey, conducted among a representative and projectable sample of U.S. gastroenterologists, revealed Fiber Choice® as the #1-recommended chewable fiber brand.1
The results of a ProVoice survey, fielded in June 2019 by IQVIA, showed Fiber Choice a strong leader in recommendations by gastroenterologists.1
This endorsement reflects ongoing good patient experiences and feedback with Fiber Choice as well as scientific news flow. In particular, the results of an important patient-reported outcomes study, entitled CIFPRO (Chewable Inulin Fiber Patient Reported Outcomes™), were peer reviewed and presented at the American College of Gastroenterology Annual Meeting in 2018.4 CIFPRO, a real-world study of patients who took Fiber Choice, provided confirmatory evidence – in combination with results from a previous randomized clinical trial5 – demonstrating improved bowel regularity, rapid symptom improvement, and patient satisfaction with Fiber Choice fiber supplement.
Inulin, the well-studied, 100 percent natural, prebiotic soluble fiber in Fiber Choice, is found in 30,000 fruits and vegetables.2 3 In clinical trials, inulin has been shown to help support digestive health, including support of regularity.4 Additionally, inulin supports the growth of the body's own beneficial bacteria, including Lactobacillus and Bifidobacterium, in the colon.
"Dietary fiber is known for keeping our bodies regular," said Michael Epstein, M.D., FACG, AGAF, a leading gastroenterologist and Chief Medical Advisor of IM HealthScience. "Most importantly, it's essential that you get enough fiber in your diet. One way to do that is to supplement your daily intake of dietary fiber with natural, prebiotic fiber supplements."
Less than 3 percent of Americans get the recommended minimum amount of fiber, and 97 percent need to increase their fiber intake.6 Although the recommended daily fiber intake is 25 to 38 grams,7 most Americans only get about half that amount. This "fiber gap" reflects a diet with relatively few high-fiber foods, such as fruits, vegetables, nuts, legumes, and whole grains, and is a large enough issue for the U.S. government to deem it a "public health concern" for most of the U.S. population.
To help bridge this gap, gastroenterologists recommend fiber supplements, including Fiber Choice chewable tablets and gummies. For physicians, it's a simple, convenient, and tasty way to help patients get the fiber needed for overall good digestive health.
Fiber Choice can be found in the digestive aisle at Walmart, CVS, Target, Rite Aid, and many other drug and food retailers.
About ProVoice Survey
IQVIA fielded a survey in June 2019 among U.S. gastroenterologists for IM HealthScience. The ProVoice survey methodology validated the claim, at a 95 percent confidence level, that "Fiber Choice® is the #1 gastroenterologist-recommended chewable fiber supplement."
About CIFPRO™ Study
Data from the patient reported CIFPRO study showed that
About Fiber Choice®
Research shows that the digestive system does more than digest food: it plays a central role in the immune system. The healthy bacteria that live in the digestive tract promote immune system function, so prebiotic fiber helps nourish the body.
The usual adult dosage with Fiber Choice Chewable Tablets is two tablets, up to three times a day, and for Fiber Choice Fiber Gummies it is two gummies, up to six per day.
About IM HealthScience®
IMH is a privately held company based in Boca Raton, Florida. It was founded in 2010 by a team of highly experienced pharmaceutical research and development and management executives. Both IMH and PS are dedicated to developing products to address overall health and wellness in digestive health and sleep. The IM HealthScience and Physician's Seal advantage comes from developing products based on patented, targeted-delivery technologies, including IPP® (Ion-Powered Pump®) and SST® (Site Specific Targeting®) technologies. For more information, visit www.imhealthscience.com to learn about the company, or www.IBgard.com, www.FDgard.com, www.FiberChoice.com, and www.REMfresh.com.
1 IQVIA, ProVoice Survey June 2019: Among gastroenterologists recommending chewable fiber tablets and gummies
This information is for educational purposes only and is not meant to be a substitute for the advice of a physician or other health care professional. You should not use this information for diagnosing a health problem or disease. The company will strive to keep information current and consistent but may not be able to do so at any specific time. Generally, the most current information can be found on www.fiberchoice.com. Individual results may vary.
SOURCE IM HealthScience